XTL Biopharmaceuticals Ltd.

Regulatory Filings • Apr 6, 2014

_________ false

C003��� �� �� ������������� ��"�2PublicX T L BIOPHARMACEUTICALS LTD4313Corporation no: 520039470Stock Exchange/Market: -11996381Medinat hayehudim st 85 , Herzliya 4614001 , ,Tel: 09-9557080 , Fax: 09-9519727E.mail address: ir@xtlbio.comReported via MAGNA: 06/04/2014              Time of broadcast: 12:43 12:36:52

Company site:		www.xtlbio.com

Reference: 2014-02-039096

Israel Securities Authority		Tel Aviv Stock Exchange
www.isa.gov.il		www.tase.co.il

Complementary report for a report sent on date 03/04/2014 whose reference number was 2014-02-037413
Main details added/ completed:
Amended F-3 pre-effective.

Other Report or AnnouncementRegulation 5 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000 The corporation is a foreign private issuer as defined by U.S. Securities Laws.

Attached hereto is a report on	FORM F-3 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933.

09_XTLBIOF-3A_Merged_isa.pdf

References of previous documents relating to this matter(the reference does not constitute incorporation by reference):
Previous names of reporting entity: XENOGRAFT TECHNOLOGIES LTD
Date of revision of form structure: 02/03/2014
- - -
Name of the Signatory: : Kntor Ronen , Position of Signatory in the reporting corporation: Legal Adviser , Name of Employer Company: .
Abba Hillel Silver Rd Telephone: 03-6133371 , Facsimile: 03-6133372 , E-mail: rkantor@kantor-law.com 2